This study is researching the treatment outcomes and long-term effects of a drug called Dupixent in treatment of patients with Eosinophilic Esophagitis (EoE).

The purpose of this study is to find out how safe and effective a new CAR-T study treatment, called MB-105, is for people with T-cell lymphoma. MB-105 is an experimental study treatment. This means it is not approved for general use by the U.S. Food and Drug Administration (FDA) and, as such, can only be used in research studies.

In this study, we are trying to understand how students feel when they look for help after going through sexual misconduct or violence. We also want to find ways to support those who have been affected.

In this study, we want to see if a new drug called petosemtamab is effective. The study is for patients who have head and neck cancer that has spread or come back and cannot be cured. We want to see if petosemtamab works better than the treatments doctors usually use.

Are you pregnant? Are you planning a scheduled cesarean delivery? If so, you may be able to take part in a study to see if using two antibiotics before a C-section instead of just one can lower the risk of infections. The infections we want to prevent are womb infection, wound infection, or a serious blood infection. Compensation provided.

Have you had an organ transplant or hematopoietic cell transplant and have advanced cutaneous squamous cell carcinoma? If so, you might be eligible to take part in a study to see if an investigation drug, RP1, can help treat your skin cancer.

Participants will meet with me on a recorded Zoom session for about 1 hour in exchange for a $20 Starbucks gift card. During this call, I'll have them complete a few tasks on the cost and financial aid pages of a few different university websites. They will not be asked to provide any personal information to these sites. The purpose of my study is to understand the challenges first-generation students and their families run into when trying to understand the cost of attending college on university websites.

In this study, we want to asses the long-term safety of using a virus to deliver a gene, AAV2-hAQP1, and how effective this gene is at treating dry mouth in people who have received radiation therapy for head and neck cancer.

We are studying an investigational drug, denifanstat, to see if it will help in the treatment of liver inflammation and scarring (fibrosis) in adults diagnosed with noncirrhotic NASH (non-alcoholic steatohepatitis) MASH (metabolic dysfunction-associated steatohepatitis).

The purpose of this study is to see how well the injection of the radiation enhancer (JNJ-90301900) into your cancer before you receive chemoradiotherapy followed by immunotherapy compares to chemoradiotherapy alone followed by immunotherapy.